€22.66
1.07%
Xetra, Jun 24, 05:45 pm CET
ISIN
DE000A288904
Symbol
COP
Index

CompuGroup Medical Stock price

€22.66
+0.62 2.81% 1M
+0.96 4.42% 6M
+0.90 4.14% YTD
-2.38 9.50% 1Y
-20.18 47.11% 3Y
-41.64 64.76% 5Y
-9.36 29.22% 10Y
-49.34 68.53% 20Y
Xetra, Closing price Wed, Jun 25 2025
+0.00 0.00%
ISIN
DE000A288904
Symbol
COP
Index
Sector

Key metrics

Basic
Market capitalization
€1.2b
Enterprise Value
€1.9b
Net debt
€698.0m
Cash
€128.6m
Shares outstanding
51.7m
Valuation (TTM | estimate)
P/E
43.58 | 13.98
P/S
1.02 | 0.98
EV/Sales
1.63 | 1.56
EV/FCF
22.15
P/B
1.80
Dividends
DPS
€0.05
Yield 1Y | 5Y
0.22% | 1.01%
Growth 1Y | 5Y
-95.00% | -36.90%
Payout 1Y | 3Y
7.58% | 52.72%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€1.2b | €1.2b
EBITDA
€206.2m | €246.1m
EBIT
€93.9m
Net Income
€27.0m | €83.8m
Free Cash Flow
€84.9m
Growth (TTM | estimate)
Revenue
-2.19% | 4.16%
EBITDA
-11.03% | 13.74%
EBIT
-18.88%
Net Income
-46.06% | 142.31%
Free Cash Flow
-8.42%
Margin (TTM | estimate)
Gross
83.85%
EBITDA
17.85% | 20.48%
EBIT
8.13%
Net
2.34% | 6.98%
Free Cash Flow
7.35%
Financial Health
Equity Ratio
32.96%
Return on Equity
5.34%
ROCE
5.85%
ROIC
3.32%
Debt/Equity
1.27
More
EPS
€0.52
FCF per Share
€1.64
Short interest
-
Employees
8.82k
Rev per Employee
€130.00k
Show more

Is CompuGroup Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

CompuGroup Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a CompuGroup Medical forecast:

3x Buy
17%
8x Hold
44%
7x Sell
39%

Analyst Opinions

18 Analysts have issued a CompuGroup Medical forecast:

Buy
17%
Hold
44%
Sell
39%

Financial data from CompuGroup Medical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,156 1,156
2% 2%
100%
- Direct Costs 187 187
76% 76%
16%
969 969
140% 140%
84%
- Selling and Administrative Expenses 582 582
6,758% 6,758%
50%
- Research and Development Expense - -
-
-
206 206
11% 11%
18%
- Depreciation and Amortization 112 112
3% 3%
10%
EBIT (Operating Income) EBIT 94 94
19% 19%
8%
Net Profit 27 27
46% 46%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about CompuGroup Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CompuGroup Medical Stock News

AD HOC NEWS
4 days ago
Dank des Rückzugs des Softwareanbieters Compugroup DE000A288904 von der Börse darf der Diagnosespezialist Stratec DE000STRA555 nach kurzer Zeit wieder in den SDax DE0009653386.
AD HOC NEWS
9 days ago
(Schlagwort in Überschrift ergänzt)ZUG - Dank des Rückzugs des Softwareanbieters Compugroup DE000A288904 von der Börse darf der Diagnosespezialist Stratec DE000STRA555 nach kurzer Zeit wieder in den SDax DE0009653386.
AD HOC NEWS
9 days ago
Dank des Rückzugs des Softwareanbieters Compugroup DE000A288904 von der Börse darf der Diagnosespezialist Stratec DE000STRA555 nach kurzer Zeit wieder in den SDax DE0009653386.
More CompuGroup Medical News

Company Profile

CompuGroup Medical SE & Co. KGaA engages in the provision of e-Health solutions. Its software products are designed to support all medical and organizational activities in doctor’s office, pharmacies, laboratories and hospitals. The company operates through the following segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Health Connectivity Services (HCS). The AIS segment focuses on practice management software and electronic medical records for office-based physicians, dentists, medical care centers and physician's networks. The PCS segment focuses on integrated clinical, administrative and financial software applications for retail pharmacies. The HIS segment focuses on clinical and administrative solutions for the inpatient sector, where health services are provided over a prolonged period of time through highly specialized, secondary care institutions. The HCS segment on customers within the healthcare sector that are outside the healthcare providers. The company was founded by Frank Gotthardt in 1987 and is headquartered in Koblenz, Germany.

Head office Germany
CEO Daniel Gotthardt
Employees 8,815
Founded 1987
Website www.cgm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today